Amivantamab with chemotherapy - Non-small cell lung cancer with EGFR exon 20 insertions

被引：0
|
作者：
Drappier, Noemie [1 ]
Pierret, Thomas [2 ]
机构：
[1] Univ Montpellier, Fac Med, F-34090 Montpellier, France
[2] Hosp Civils Lyon, Hop Louis Pradel, Serv Hosp Univ Pneumol, F-69500 Bron, France
来源：
BULLETIN DU CANCER | 2024年 / 111卷 / 12期
关键词：
Non-small cell lung cancer; EGFR exon 20 insertions; Amivantamab; Chemotherapy;
D O I：
10.1016/j.bulcan.2024.08.014
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1085 / 1087
页数：3
相关论文
共 50 条
  • [31] Characteristics, treatment patterns, and clinical outcomes in patients with advanced non-small cell lung cancer harboring EGFR exon 20 insertions
    Liao, Ying-Ting
    Wang, Lei-Chi
    Sun, Ruei-Lin
    Yeh, Yi-Chen
    Huang, Hsu-Ching
    Shen, Chia-, I
    Tseng, Yen-Han
    Hsiao, Tsu-Hui
    Chao, Heng-Sheng
    Luo, Yung-Hung
    Chen, Yuh-Min
    Chiang, Chi-Lu
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (12) : 10365 - 10376
  • [32] Mechanisms of resistance to CLN-081 (TAS6417) in non-small cell lung cancer with EGFR exon 20 insertions
    Hayashida, Takuma
    Kagawa, Yosuke
    Mori, Shunta
    Jie, Liu
    Kashima, Yukie
    Tanaka, Kosuke
    Udagawa, Hibiki
    Izumi, Hiroki
    Kobayashi, Susumu
    CANCER RESEARCH, 2022, 82 (12)
  • [33] Characteristics, treatment patterns, and clinical outcomes in patients with advanced non-small cell lung cancer harboring EGFR exon 20 insertions
    Ying-Ting Liao
    Lei-Chi Wang
    Ruei-Lin Sun
    Yi-Chen Yeh
    Hsu-Ching Huang
    Chia-I Shen
    Yen-Han Tseng
    Tsu-Hui Hsiao
    Heng-Sheng Chao
    Yung-Hung Luo
    Yuh-Min Chen
    Chi-Lu Chiang
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 10365 - 10376
  • [34] Evaluating the Clinical Characteristics and Prognosis of Advanced Non-Small Cell Lung Cancer with Exon 20 Insertions
    Wang, Haibo
    Xu, Yiquan
    Lin, Jinlan
    Huang, Yunjian
    CANCER CONTROL, 2024, 31
  • [35] ERBB2 exon 20 insertions are rare in Brazilian non-small cell lung cancer
    Cavagna, Rodrigo de Oliveira
    Zaniolo, Beatriz Garbe
    de Paula, Flavia Escremim
    Berardinelli, Gustavo Noriz
    Santana, Iara
    Albino da Silva, Eduardo Caetano
    Dias, Josiane Mourao
    Jacinto, Alexandre Arthur
    Noleto da Nobrega Oliveira, Rachid Eduardo
    de Marchi, Pedro
    Leal, Leticia Ferro
    Reis, Rui Manuel
    THORACIC CANCER, 2022, 13 (23) : 3402 - 3407
  • [36] New therapies in non-small cell lung cancer with EGFR exon 20 insertion mutations
    David, Gil-Sierra Manuel
    del Pilar, Briceno-Casado Maria
    Cristina, Moreno-Ramos
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023, 29 (04) : 934 - 943
  • [37] Erlotinib Response in a Non-Small Cell Lung Cancer Patient with EGFR Exon 20 Mutation
    Korkmaz, Levent
    Artac, Mehmet
    Karaagac, Mustafa
    Er, Zehra
    Boruban, Melih C.
    Poyraz, Necdet
    Kaya, Bugra
    Tavli, Lema
    Odev, Kemal
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2016, 26 (01): : 64 - 66
  • [38] A new era for EGFR exon20 targeting in non-small cell lung cancer
    Christopoulos, Petros
    CHINESE CLINICAL ONCOLOGY, 2025, 14 (01)
  • [39] CLINICAL CHARACTERISTICS OF NON-SMALL CELL LUNG CANCER WITH EGFR GENE MUTATIONS IN EXON 20
    Miyanaga, A.
    Akagi, K.
    Takeuchi, S.
    Kurimoto, F.
    Iijima, Y.
    Yoshino, N.
    Mikami, I.
    Akiyama, H.
    Sakai, H.
    LUNG CANCER, 2009, 64 : S54 - S54
  • [40] A case of non-small cell lung cancer with EGFR exon 20 insertion treated with osimertinib
    Morton-Gittens, Jamie
    Pipalia, Nisarg
    Liu, Hongxiang
    Thippu Jayaprakash, Kamalram
    LUNG CANCER, 2021, 156 : S73 - S74
12345